Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Novartis
>
Regulatory Environment does affect Rep Employment
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 5153750"]Forbes 8/20/2009 - </p><p>Why Pharma Wants ObamaCare</p><p><br /></p><p>And one of the biggest forces working toward that goal is America’s biggest pharmaceutical companies, which are expected to pour as much as $150 million into advertisements supporting the reform effort.</p><p><br /></p><p>The only reason anybody is shocked is because they weren’t paying attention. </p><p><br /></p><p><a href="http://www.forbes.com/2009/08/19/pharmaceuticals-obamacare-reform-business-healthcare-washington.html" target="_blank" class="externalLink ProxyLink" data-proxy-href="http://www.forbes.com/2009/08/19/pharmaceuticals-obamacare-reform-business-healthcare-washington.html" rel="nofollow">http://www.forbes.com/2009/08/19/pharmaceuticals-obamacare-reform-business-healthcare-washington.html</a></p><p><br /></p><p>ABC News 6/8/2012 - Memos Unveil How White House Worked With PhRMA To Sell ObamaCare</p><p><br /></p><p>"Memos released Friday by the House Energy and Commerce Committee reveal the Obama administration coordinated a $150 million advertising campaign with pharmaceutical companies in support of the 2010 Affordable Care Act."</p><p><br /></p><p>"E-mails obtained by the Energy and Commerce Committee show that the White House traded billions of dollars in policy concessions to PhRMA for millions of dollars worth of advertising," House Speaker John Boehner, R-Ohio, said today. "The administration created and managed a super-PAC paid for by PhRMA and run by Jim Messina out of the West Wing of the White House. This is wrong and the administration must be held accountable for their actions.”</p><p><br /></p><p><a href="http://abcnews.go.com/Politics/memos-unveil-how-white-house-worked-with-phrma-to-sell-obamacare/blogEntry?id=16529007&ref=https%3A%2F%2Fwww.google.com%2F" target="_blank" class="externalLink ProxyLink" data-proxy-href="http://abcnews.go.com/Politics/memos-unveil-how-white-house-worked-with-phrma-to-sell-obamacare/blogEntry?id=16529007&ref=https%3A%2F%2Fwww.google.com%2F" rel="nofollow">http://abcnews.go.com/Politics/memos-unveil-how-white-house-worked-with-phrma-to-sell-obamacare/blogEntry?id=16529007&ref=https://www.google.com/</a></p><p><br /></p><p>Forbes 5/25/2013 - Obamacare Will Bring Drug Industry $35 Billion In Profits</p><p><br /></p><p>Despite expiring patents on blockbuster drugs and a wave of new regulation from the Affordable Care Act that will cost drug makers, the pharmaceutical industry will reap between “$10 billion and $35 billion in additional profits over the next decade,” a new analysis shows.</p><p><br /></p><p>The health law, which will bring millions of uninsured Americans health benefits beginning in January 2014, will be a critical boon to pharmaceutical industry balance sheets, increasing revenue by one-third by the end of the decade, according to a new report from research and consulting firm GlobalData of London. That means the U.S. pharmaceutical industry’s market value will mushroom by 33 percent to $476 billion in 2020 from $359 billion last year.</p><p><br /></p><p><a href="http://www.forbes.com/sites/brucejapsen/2013/05/25/obamacare-will-bring-drug-industry-35-billion-in-profits/" target="_blank" class="externalLink ProxyLink" data-proxy-href="http://www.forbes.com/sites/brucejapsen/2013/05/25/obamacare-will-bring-drug-industry-35-billion-in-profits/" rel="nofollow">http://www.forbes.com/sites/brucejapsen/2013/05/25/obamacare-will-bring-drug-industry-35-billion-in-profits/</a></p><p><br /></p><p>Huffington Post 5/25/11 - Obama worked cut a deal with PRMA</p><p><br /></p><p>"In exchange, the Pharmaceutical Researchers and Manufacturers Association (PhRMA) agreed to cut $80 billion in projected costs to taxpayers and senior citizens over ten years. Or, as the memo says: "Commitment of up to $80 billion, but not more than $80 billion.”</p><p><br /></p><p>RS - Annual Fee on Branded Prescription Drug Manufacturers and Importers</p><p><br /></p><p>Section 9008 of the Patient Protection and Affordable Care Act (ACA), Public Law 111-148 (124 Stat. 119 (2010)), as amended by section 1404 of the Health Care and Education Reconciliation Act of 2010 (HCERA), Public Law 111-152 (124 Stat. 1029 (2010)), imposes an annual fee on each covered entity engaged in the business of manufacturing or importing branded prescription drugs, to be paid not later than September 30th of each year. </p><p><br /></p><p>ee Year</p><p>Applicable Amount</p><p>2011</p><p>$2.5 billion</p><p>2012</p><p>$2.8 billion</p><p>2013</p><p>$2.8 billion</p><p>2014</p><p>$3 billion</p><p>2015</p><p>$3 billion</p><p>2016</p><p>$3 billion</p><p>2017</p><p>$4 billion</p><p>2018</p><p>$4.1 billion</p><p>2019 and thereafter</p><p>$2.8 billion</p><p><br /></p><p><a href="http://www.irs.gov/Businesses/Corporations/Annual-Fee-on-Branded-Prescription-Drug-Manufacturers-and-Importers" target="_blank" class="externalLink ProxyLink" data-proxy-href="http://www.irs.gov/Businesses/Corporations/Annual-Fee-on-Branded-Prescription-Drug-Manufacturers-and-Importers" rel="nofollow">http://www.irs.gov/Businesses/Corporations/Annual-Fee-on-Branded-Prescription-Drug-Manufacturers-and-Importers</a></p><p><br /></p><p><br /></p><p>And Novartis and other members of PRMA have paid for the costs of that advertising effort and these increased fees that they agreed to by laying-off, among others, Pharma Reps.</p><p><br /></p><p>40,000 have left the industry in since 2010. That’s about $6B in cost savings.[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 5153750"]Forbes 8/20/2009 - Why Pharma Wants ObamaCare And one of the biggest forces working toward that goal is America’s biggest pharmaceutical companies, which are expected to pour as much as $150 million into advertisements supporting the reform effort. The only reason anybody is shocked is because they weren’t paying attention. [url]http://www.forbes.com/2009/08/19/pharmaceuticals-obamacare-reform-business-healthcare-washington.html[/url] ABC News 6/8/2012 - Memos Unveil How White House Worked With PhRMA To Sell ObamaCare "Memos released Friday by the House Energy and Commerce Committee reveal the Obama administration coordinated a $150 million advertising campaign with pharmaceutical companies in support of the 2010 Affordable Care Act." "E-mails obtained by the Energy and Commerce Committee show that the White House traded billions of dollars in policy concessions to PhRMA for millions of dollars worth of advertising," House Speaker John Boehner, R-Ohio, said today. "The administration created and managed a super-PAC paid for by PhRMA and run by Jim Messina out of the West Wing of the White House. This is wrong and the administration must be held accountable for their actions.” [url]http://abcnews.go.com/Politics/memos-unveil-how-white-house-worked-with-phrma-to-sell-obamacare/blogEntry?id=16529007&ref=https%3A%2F%2Fwww.google.com%2F[/url] Forbes 5/25/2013 - Obamacare Will Bring Drug Industry $35 Billion In Profits Despite expiring patents on blockbuster drugs and a wave of new regulation from the Affordable Care Act that will cost drug makers, the pharmaceutical industry will reap between “$10 billion and $35 billion in additional profits over the next decade,” a new analysis shows. The health law, which will bring millions of uninsured Americans health benefits beginning in January 2014, will be a critical boon to pharmaceutical industry balance sheets, increasing revenue by one-third by the end of the decade, according to a new report from research and consulting firm GlobalData of London. That means the U.S. pharmaceutical industry’s market value will mushroom by 33 percent to $476 billion in 2020 from $359 billion last year. [url]http://www.forbes.com/sites/brucejapsen/2013/05/25/obamacare-will-bring-drug-industry-35-billion-in-profits/[/url] Huffington Post 5/25/11 - Obama worked cut a deal with PRMA "In exchange, the Pharmaceutical Researchers and Manufacturers Association (PhRMA) agreed to cut $80 billion in projected costs to taxpayers and senior citizens over ten years. Or, as the memo says: "Commitment of up to $80 billion, but not more than $80 billion.” RS - Annual Fee on Branded Prescription Drug Manufacturers and Importers Section 9008 of the Patient Protection and Affordable Care Act (ACA), Public Law 111-148 (124 Stat. 119 (2010)), as amended by section 1404 of the Health Care and Education Reconciliation Act of 2010 (HCERA), Public Law 111-152 (124 Stat. 1029 (2010)), imposes an annual fee on each covered entity engaged in the business of manufacturing or importing branded prescription drugs, to be paid not later than September 30th of each year. ee Year Applicable Amount 2011 $2.5 billion 2012 $2.8 billion 2013 $2.8 billion 2014 $3 billion 2015 $3 billion 2016 $3 billion 2017 $4 billion 2018 $4.1 billion 2019 and thereafter $2.8 billion [url]http://www.irs.gov/Businesses/Corporations/Annual-Fee-on-Branded-Prescription-Drug-Manufacturers-and-Importers[/url] And Novartis and other members of PRMA have paid for the costs of that advertising effort and these increased fees that they agreed to by laying-off, among others, Pharma Reps. 40,000 have left the industry in since 2010. That’s about $6B in cost savings.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Novartis
>
Regulatory Environment does affect Rep Employment
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Novartis
>
Regulatory Environment does affect Rep Employment
>